DURAMED PHARMACEUTICALS INC
S-3, EX-23.1, 2000-06-02
PHARMACEUTICAL PREPARATIONS
Previous: DURAMED PHARMACEUTICALS INC, S-3, EX-5, 2000-06-02
Next: DURAMED PHARMACEUTICALS INC, S-3, EX-24, 2000-06-02



<PAGE>   1

                                                                    EXHIBIT 23.1


                         CONSENT OF INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of Duramed
Pharmaceuticals, Inc., for the registration of 3,515,092 shares of its common
stock.

We also consent to the incorporation by reference therein of our report dated
March 29, 2000, with respect to the consolidated financial statements and
schedule of Duramed Pharmaceuticals, Inc. for the years ended December 31, 1999,
1998, and 1997 included in the Annual Report (Form 10-K) for 1999 filed with the
Securities and Exchange Commission.


                                        ERNST & YOUNG LLP

Cincinnati, Ohio
June 2, 2000






















© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission